Abstract
A comparison of protein expression profiles in intestinal and diffuse gastric tumors and normal tissues by 2D gel electrophoresis identified three proteins (SOD2, S100A6, and TXN) overexpressed in tumors. SOD2 and TXN were more frequently overexpressed in diffuse tumors than in intestinal ones. Based on the published data on comparative 2DE protein expression analysis, a control panel of eleven proteins overexpressed in gastric tumors was compiled. A bioinformatic search for the respective mRNAs in the Oncomine database (representing mRNA transcription levels in tumor vs. normal tissues) showed the agreement of proteomic and transcriptomic data for seven of 11 proteins.
Similar content being viewed by others
Abbreviations
- GC:
-
gastric cancer
- 2DE:
-
two-dimensional gel electrophoresis
- DB:
-
database
References
Alexander H.R. 1992. Cancer of the stomach. In: Cancer: Principles and Practice of Oncology, vol. 1. Eds. DeVita V.T., Jr., Rosenberg S.A. Philadelphia: Lippincott, pp. 818–848.
Fujiwara Y., Doki Y., Taniguchi H., Sohma I., Takiguchi S., Miyata H., Yamasaki M., Monden M. 2007. Genetic detection of free cancer cells in the peritoneal cavity of the patient with gastric cancer: Present status and future perspectives. Gastric Cancer, 10, 197–204.
Katoh M. 2005. Epithelial-mesenchymal transition in gastric cancer. Int. J. Oncol. 27, 1677–1683.
Hamilton S.R., Aaltonen A.A. 2000. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press.
Krasnov G.S., Oparina N.Yu., Hankin S.L., Mashkova T.D., Ershov A.N., Zatsepina O.G., Karpov V.L., Beresten S.F. 2009. Identification of proteins with altered expression in colorectal cancer by means of 2D-proteomics. Mol. Biol. (Moscow). 43, 321–328.
Bradford M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–254.
Laemmly U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227, 680–685.
Mortz E., Krogh T., Vorum H., Gorg A. 2001. Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics. 1, 1359–1363.
Grogan T.M., Fenoglio-Prieser C., Zeheb R., Bellamy W., Frutiger Y., Vela E., Stemmerman G.., Macdonald J., Richter L., Gallegos A., Powis G.. 2000. Thioredoxin, a putative oncogene product, is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival. Hum. Pathol. 31, 475–481.
Takeno A., Takemasa I., Doki Y., Yamasaki M., Miyata H., Takiguchi S., Fujiwara Y., Matsubara K, Monden M. 2008. Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis. Br. J. Cancer. 99, 1307–1315.
Yang Y.Q., Zhang L.J., Dong H., Jiang C.L., Zhu Z.G., Wu J.X., Wu Y.L., Han J.S., Xiao H.S., Gao H.J., Zhang Q.H. 2007. Upregulated expression of S100A6 in human gastric cancer. J. Dig. Dis. 8, 186–193.
Sipina L.V., Bukurova Yu.A., Nikitina I.G., Krasnov G.S., Sergeev S.A., Lisitsyn N.A., Karpov V.L., Beresten’ S.F. 2010. Identification of proteins overexpressed in papillary thyroid tumors. Biokhimiya (Moscow). 75, 1148–1152.
Nedjadi T., Kitteringham N., Campbell F., Jenkins R.E., Park B.K., Navarro P., Ashcroft F., Tepikin A., Neoptolemos J.P., Costello E. 2009. S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility. Br. J. Cancer. 101, 1145–1154.
Komatsu K., Andoh A., Ishiguro S., Suzuki N., Hunai H., Kobune-Fujiwara Y., Kameyama M., Miyoshi J., Akedo H., Nakamura H. 2000. Increased expression of S100A6 (calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas. Clin. Cancer Res. 6, 172–177.
Ishii A., Suzuki M., Satomi K., Kobayashi H., Sakashita S., Kano J., Pei Y., Minami Y., Ishikawa S., Noguchi M. 2009. Increased cytoplasmic S100A6 expression is associated with pulmonary adenocarcinoma progression. Pathol. Int. 59, 623–630.
Raffel J., Bhattacharyya A.B., Gallegos A., Cui H., Einspahr J.G., Alberts D.S., Powis G. 2003. Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival. J. Lab. Clin. Med. 142, 46–51.
Noda N., Ochiai A., Miyuazaki K., Sigimura T., Terada M., Wakasigi H. 2000. Detection of thioredoxin in gastric cancer: Association with histological type. Antioxid. Redox Signal. 2, 519–528.
Dairkee S.H., Nicolau M., Sayeed A., Champion S., Ji Y., Moore D.H., Yong B., Meng Z., Jeffrey S.S. 2007. Oxidative stress pathways highlighted in tumor cell immortalization: Association with breast cancer outcome. Oncogene. 26, 6269–6279.
Kaimul A.M., Nakamura H., Masutani H., Jodoi J. 2007. Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome. Free Radic. Biol. Med. 43, 861–868.
Bag A., Bag N. 2008. Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: A review. Cancer Epidemiol. Biomarkers Prev. 17, 3298–3305.
Oien K.A., Vass J.K., Downie I., Fullarton G., Keith W.N. 2003. Profiling, comparison and validation of gene expression in gastric carcinoma and normal stomach. Oncogene. 22, 4287–4300.
El-Rifai W., Moskaluk C.A., Abdrabbo M.A., Herper J., Yoshida C., Riggins G.J., Frierson H.F., Powell S.M. 2002. Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res. 62, 6823–6826.
Li W., Li J.F., Qu Y., Chen X.H., Qin J.M., Gu Q.L., Yan M., Zhu Z.G., Liu B.Y. 2008. Comparative proteomics analysis of human gastric cancer. World J. Gastroenterol. 14, 5657–5664.
Imano M., Satou T., Itoh T., Sakai K., Ishimaru E., Yasuda A., Peng Y.F., Shinkai M., Akai F., Yasuda T., Imamoto H., Okuno K., Ito H., Shiozaki H., Ohyanagi H. 2009. Immunohistochemical expression of osteopontin in gastric cancer. J. Gastrointest. Surg. 13, 1577–15782.
Yoshihara T., Kadota Y., Yoshimura Y., Tatano Y., Takeuchi N., Okitsu H., Umemoto A., Yamauchi T., Itoh K. 2006. Proteomic alteration in gastic adenocarcinomas from Japanese patients. Mol. Cancer. 25, 5–75.
Oki M., Yamamoto H., Taniguchi H., Adachi Y., Imai K., Shinomura Y. 2008. Overexpression of the receptor tyrosine kinase EphA4 in human gastric cancers. World J. Gastroenterol. 14, 5650–5656.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © E.S. Grigorieva, Yu.A. Bukurova, G.S. Krasnov, S.G. Afanas’ev, N.V. Cherdyntseva, S.A. Tuzikov, E.L. Choinzonov, V.L. Karpov, N.A. Lisitsyn, S.F. Beresten, 2011, published in Molekulyarnaya Biologiya, 2011, Vol. 45, No. 4, pp. 738–743.
Rights and permissions
About this article
Cite this article
Grigorieva, E.S., Bukurova, Y.A., Krasnov, G.S. et al. Identification of proteins overexpressed in malignant gastric tumors: Comparison of results obtained by 2DE and bioinformatic search. Mol Biol 45, 680–685 (2011). https://doi.org/10.1134/S0026893311030058
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893311030058